Hyloris Pharmaceuticals SA logo

Hyloris Pharmaceuticals SA

EBR:HYL.BR

Overview | Financials
Company Name Hyloris Pharmaceuticals SA
Symbol HYL.BR
Currency EUR
Price 5.96
Market Cap 166,882,384
Dividend Yield 0%
52-week-range 2.89 - 14.1
Industry Biotechnology
Sector Healthcare
CEO Mr. Stijn Van Rompay
Website https://hyloris.com

An error occurred while fetching data.

About Hyloris Pharmaceuticals SA

Hyloris Pharmaceuticals SA engages in the develop, manufacture, and deliver pharmaceutical products to address unmet medical needs in cardiovascular health, oncology, women's health, and other major therapeutic areas. The company offers cardiovascular products for atrial fibrillation, acute coronary syndrome, advanced heart failure, congestive heart failure, acute coronary syndrome, and coronary

Related Stocks

LNA Santé SA logo

LNA Santé SA

LNA.PA

22.35 EUR

Inventiva S.A. logo

Inventiva S.A.

IVA.PA

1.982 EUR

Clínica Baviera, S.A. logo

Clínica Baviera, S.A.

CBAV.MC

36.9 EUR

AB Science S.A. logo

AB Science S.A.

AB.PA

1.034 EUR

Lumibird SA logo

Lumibird SA

LBIRD.PA

9.5 EUR

Cegedim SA logo

Cegedim SA

CGM.PA

12.55 EUR

Ion Beam Applications SA logo

Ion Beam Applications SA

IBAB.BR

13.64 EUR

Q & M Dental Group (Singapore) Limited logo

Q & M Dental Group (Singapore) Limited

QC7.SI

0.28 SGD

Atrys Health, S.A. logo

Atrys Health, S.A.

ATRY.MC

3.14 EUR

Profarma Distribuidora de Produtos Farmacêuticos S.A. logo

Profarma Distribuidora de Produtos Farmacêuticos S.A.

PFRM3.SA

6.23 BRL

Financials

Numbers are in millions USD

Numbers are in millions USD